Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antiherpesvirus agent from Roche

March 13, 1997

Antifungal agents from Nihon Nohyaku

March 13, 1997

GS-4104 enters human testing

March 12, 1997

SKB's Vectavir introduced in Germany

March 12, 1997

Genome Therapeutics and Versicor collaborate on new antibacterial compounds

March 12, 1997

New antibacterial agents from Daiichi

March 12, 1997

Antibacterial agent isolated by Sanwa Kagaku

March 12, 1997

Sankyo prepares antifungal agents

March 11, 1997

Synsorb sponsors research on carbohydrate synthesis

March 10, 1997

New antifungal agents from Lilly

March 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...